Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2012 Authors' conclusions In this update to a previous report, no new clinical studies or guidelines regarding the use of cannabinoids for the treatment of post-traumatic stress disorder were identified. Indexing Status Subject indexing assigned by CRD MeSH Cannabinoidss; Stress Disorders, Post-Traumatic Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: htainfo@cadth.ca AccessionNumber 32012000694 Date abstract record published 29/09/2012 |
